期刊文献+

Development of a nomogram to predict progression-free survival in patients with locally advanced renal cell carcinoma 被引量:1

原文传递
导出
摘要 To the Editor:Renal cell carcinoma(RCC)accounts for approximately 3%of all malignancies in adults.[1]Locally advanced RCC has a relatively distinct and adverse prognosis with a 5-year cancer specific survival(CSS)rate ranging from 28%to 67%after curative surgery.[2]It is important to accurately stratify the risk of disease recurrence for locally advanced RCC.Several prognostic models like Stage,Size,Grade,and Necrosis(SSIGN),Leibovich,Cindolo,Yaycioglu,Memorial Sloan Kettering Cancer Center(MSKCC),Kattan,and Karakiewicz have been developed to predict the prognosis of localized RCC and the concordance index(C-index)has been found to range from 0.65 to 0.84.[3,4]To our knowledge,these models have mainly been developed based on the data from low-risk patients with RCC.In an external prospec-tive cohort comprising patients with intermediate or high-risk RCC,the performances of these models were found to be sharply decreased(C-index range from 0.587 to 0.69).[4]Thus,in this study,we aimed to develop a more accurate prognostic model for better risk stratification in locally advanced RCC.
机构地区 Department of Urology
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2021年第22期2765-2767,共3页 中华医学杂志(英文版)
  • 相关文献

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部